3 20 Abstract 21 Background 22 Severe fever with thrombocytopenia syndrome (SFTS), caused by SFTS virus (SFTSV), 23 is a viral hemorrhagic fever with a high case fatality rate. Favipiravir was reported to be 24 effective in the treatment of SFTSV infection in vivo in type I interferon receptor 25 knockout (IFNAR −/− ) mice at treatment dosages of both 60 mg/kg/day and 300 26 mg/kg/day for a duration of 5 days. 27 Methods 28 In this study, the efficacy of favipiravir at dosages of 120 mg/kg/day and 200 mg/kg/day 29 against SFTSV infection in an IFNAR −/− mouse infection model was investigated.
